Expanding EPD Business Supports ABT Stock Amid Macro Issues

Abbott’s (ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. Yet, the international business environment continues to be challenging. The stock carries a Zacks Rank #3 (Hold).Factors Driving ABT SharesAbbott’s Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In a relatively short span, FreeStyle Libre has achieved global leadership among continuous glucose monitorin ...